Stanley-Laman Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,168	Closed	-$329K	–	279
2019 Q2	$329K	Hold	2,168	–	–	0.08%	219
2019 Q1	$258K	Buy	2,168 +50	+2%	+$5.95K	0.06%	234
2018 Q4	$231K	Buy	+2,118	New	+$231K	0.06%	235